Navigation Links
NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas
Date:1/8/2009

e show, which attracts more than 5,000 industrial, academic, business and governmental attendees from around the word. It is the largest gathering of the nanotechnology industry in the U.S. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with offices in California and Switzerland.


'/>"/>
SOURCE Nano Science and Technology Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...romises ultra-fast communication, computation and ...n. But trying to use quantum states as carriers of...w two physicists have shown, mathematically, how t...nication, while keeping the information intact. Th...ical Review Letters and highlighted with a Viewpo...
(Date:11/23/2009)...N,Nov.23/PRNewswire-FirstCall/-YMBioSciencesInc.(N...entcompanythatidentifiesandadvancesadiverseportfol...ofdevelopment,todayreportedthatCytopia(ASX:CYT)has...87,apotent,orally-administeredJAK1/JAK2inhibitor.T...nesota.AproposaltomergeCytopiaintoYMhasbeenpreviou...
(Date:11/23/2009)...3/PRNewswire/--ImmuneDesignC or p.(IDC)announcedto...airman.Dr.Carterhasasuccessfultrackrec or dinbiote...xecutiveOfficeratZymoGenetics,inSeattle,WAandChief...k. ,, (Photo: http://www.newscom.com/cgi-bin/pr...nderandChiefExecutiveOfficercommented,"Iamdelighte...
(Date:11/23/2009)...alif.,Nov.23/PRNewswire/--PearlTherapeuticsInc.,ab...tsforthetreatmentofchronicrespiratorydiseases,toda...BoardofDirectors.Mr.Rosenhas25yearsofexperienceint...ngkeyrolesatGileadSciencesandALZACorporation.Hisap...rdtosix. ,, "Howiebringsawealthofproductdevelop...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2
...-FirstCall/ - Dr. Brad Thompson, President and CEO...NCY ), is scheduled to present a corporate overvie...April 29 at 9:00 a.m. (ET). The conference will be...ril 28-30, 2009. , , About BioFinance , , BioFin...nada for the life sciences industry. This three-da...
...Corporation (Nasdaq: VOLC ), a leader in the dev...the diagnosis and treatment of coronary and periph...report its operating results for the first quarter...y will hold a conference call to discuss its finan...interested parties at 2 p.m., Pacific Daylight Tim...
...ohort Shows Nine of 14 Evaluable Patients Receivin...clitaxel Achieved an Objective Tumor Response - , ... Trial with Target of Enrolling 46 Patients Overal...aceuticals, Inc. (Nasdaq: PPHM ), today announce...trial evaluating bavituximab in combination with c...
Other Biology Technology:Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009 2Volcano Corporation Schedules First Quarter Conference Call, Webcast 2Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial 2Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial 3Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial 4
(Date:11/23/2009)...s available in German . , Not just birds, b...every year. Researchers at Princeton University in...thology in Radolfzell, Germany studied the migrato... the so-called "Vespertilionidae" with the help of...ration over short as well as long distances of var...
(Date:11/22/2009)...hildren exposed prenatally to tobacco smoke and du...sk for ADHD, according to research done at Cincinn...udy estimates that up to 35 percent of ADHD cases ...reduced by eliminating both of these environmental...0 children , "Tobacco and lead exposure each ha...
(Date:11/22/2009)...ine Life scientists have inventoried an astonishin...a species that have never known sunlight - creatur...world down to 5,000 meters (~3 miles) below the oc...onar and other vanguard technologies, animals know...er 17,650, a diverse collection of species ranging...
Breaking Biology News(10 mins):We're off then: The evolution of bat migration 2Exposure to lead, tobacco smoke raises risk of ADHD 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Pine Nut Oil org Presents Best Price for Pine Nut Oil 57414 1Pine Nut Oil org Presents Best Price for Pine Nut Oil 57414 2Pine Nut Oil org Presents Best Price for Pine Nut Oil 57414 3Pine Nut Oil org Presents Best Price for Pine Nut Oil 57414 4Pine Nut Oil org Presents Best Price for Pine Nut Oil 57414 5Prime Staffing Awarded Certification from The Joint Commission 57411 1Prime Staffing Awarded Certification from The Joint Commission 57411 2Riverside County Community Agencies Participate in Senior Sensitivity Training Provided by SCAN Health Plan 57408 1Riverside County Community Agencies Participate in Senior Sensitivity Training Provided by SCAN Health Plan 57408 2
...igating the carbon sink capacity of northern terre...the net carbon uptake period (CUP) has on average ...t carbon uptake of northern ecosystems is decreasi...ndings recently published January 3rd, in the jour...ystems is particularly sensitive to climatic chang...
...Thomas Jefferson University Hospital and Jefferson...a first-of-its kind study on the effect high dose ...searchers from the Jefferson-Myrna Brind Center of...conjunction with the National Institutes of Health...ow the progression of the deadly disease. , This...
...ears to significantly increase the risk that indiv...evelop hepatocellular carcinoma (HCC), a liver tum.... In the January 2 Journal of the American Medica...ral Hospital (MGH) Cancer Center and colleagues in...in the epidermal growth factor (EFG) gene may grea...
Other Biology News:Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients 2Gene variation may elevate risk of liver tumor in patients with cirrhosis 2Gene variation may elevate risk of liver tumor in patients with cirrhosis 3
...tallography services for structure-based drug desi...s pharmaceutical and biotechnology clients. Fragme...ke fragments to the active sites of crystallized p...p novel, high-affinity inhibitors. Relying on stat...
...a System (CDS) now provides integrated instrument ...data processing and reporting for the Thermo Scien...e HPLC instrument has been designed to maximize th...m column particle technology and enables LC and LC...
Denhardt's powder mixture (for 50X stock solution) from AppliChem GmbH
...ve and specific detection of microRNAs (miRNAs) by...ave high binding affinity and discrimination, enab...s. Due to the high binding affinity of the miRCURY... needed compared to traditional probes. Furthermor...
Biology Products: